Tumor-associated antigen-specific T cell (TAA-T) Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Washington D.C., District of Columbia1 trial

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients with High Risk Solid Tumors

Children's National Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.